Thomas J. Schall Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas J. Schall.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas J. Schall. Thomas J. Schall is President and CEO in ChemoCentryx, Inc. ($CCXI).
Latest Insider Trading Transactions of Thomas J. Schall
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 65.87 | 54,600 | 3,596,502 | 54,600 | |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 0.00 | 79,000 | 0 | 79,000 | |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 34,566 | 0 | 69,134 | |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 23,333 | 0 | 23,334 | |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 30,000 | 0 | 0 | |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Payment of Exercise | F | 61.92 | 47,576 | 2,945,906 | 2,308,880 | 2.4 M to 2.3 M (-2.02 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 34,566 | 0 | 2,356,456 | 2.3 M to 2.4 M (+1.49 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 23,333 | 0 | 2,321,890 | 2.3 M to 2.3 M (+1.02 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 30,000 | 0 | 2,298,557 | 2.3 M to 2.3 M (+1.32 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 17,619 | 252,128 | 6,988 | |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 11,153 | 159,599 | 24,607 | |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 65.01 | 17,619 | 1,145,450 | 2,268,557 | 2.3 M to 2.3 M (-0.77 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 17,619 | 252,128 | 2,286,176 | 2.3 M to 2.3 M (+0.78 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 65.03 | 11,153 | 725,246 | 2,268,557 | 2.3 M to 2.3 M (-0.49 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 11,153 | 159,599 | 2,279,710 | 2.3 M to 2.3 M (+0.49 %) |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 2,000 | 28,620 | 35,760 | |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 88,753 | 1,270,055 | 37,760 | |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 65.04 | 2,000 | 130,090 | 2,268,557 | 2.3 M to 2.3 M (-0.09 %) |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 2,000 | 28,620 | 2,270,557 | 2.3 M to 2.3 M (+0.09 %) |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 65.08 | 88,753 | 5,775,877 | 2,268,557 | 2.4 M to 2.3 M (-3.77 %) |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 88,753 | 1,270,055 | 2,357,310 | 2.3 M to 2.4 M (+3.91 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 35,865 | 513,228 | 126,513 | |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 70,608 | 1,010,400 | 162,378 | |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 4,201 | 60,116 | 232,986 | |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 57.75 | 35,865 | 2,071,100 | 2,268,557 | 2.3 M to 2.3 M (-1.56 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 35,865 | 513,228 | 2,304,422 | 2.3 M to 2.3 M (+1.58 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 56.14 | 16,029 | 899,874 | 2,268,557 | 2.3 M to 2.3 M (-0.70 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 55.33 | 54,579 | 3,019,856 | 2,284,586 | 2.3 M to 2.3 M (-2.33 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 70,608 | 1,010,400 | 2,339,165 | 2.3 M to 2.3 M (+3.11 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 55.01 | 4,201 | 231,115 | 2,268,557 | 2.3 M to 2.3 M (-0.18 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 4,201 | 60,116 | 2,272,758 | 2.3 M to 2.3 M (+0.19 %) |
May 07 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 8,851 | 126,658 | 237,187 | |
May 07 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 55.01 | 8,851 | 486,851 | 2,268,557 | 2.3 M to 2.3 M (-0.39 %) |
May 07 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 8,851 | 126,658 | 2,277,408 | 2.3 M to 2.3 M (+0.39 %) |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 46.59 | 71,500 | 3,331,185 | 71,500 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 0.00 | 103,700 | 0 | 103,700 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 40,844 | 584,478 | 246,038 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 50.35 | 40,844 | 2,056,691 | 2,268,557 | 2.3 M to 2.3 M (-1.77 %) |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 40,844 | 584,478 | 2,309,401 | 2.3 M to 2.3 M (+1.80 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 15,341 | 219,530 | 286,882 | |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 63,340 | 906,395 | 302,223 | |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 51.10 | 29 | 1,482 | 2,268,557 | 2.3 M to 2.3 M (0.00 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 50.21 | 15,312 | 768,814 | 2,268,586 | 2.3 M to 2.3 M (-0.67 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 15,341 | 219,530 | 2,283,898 | 2.3 M to 2.3 M (+0.68 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 51.14 | 7,723 | 394,977 | 2,268,557 | 2.3 M to 2.3 M (-0.34 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 50.41 | 55,617 | 2,803,536 | 2,276,280 | 2.3 M to 2.3 M (-2.39 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 63,340 | 906,395 | 2,331,897 | 2.3 M to 2.3 M (+2.79 %) |
Feb 06 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 119,525 | 1,710,403 | 365,563 | |
Feb 06 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 45.18 | 119,525 | 5,400,701 | 2,268,557 | 2.4 M to 2.3 M (-5.01 %) |
Feb 06 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 119,525 | 1,710,403 | 2,388,082 | 2.3 M to 2.4 M (+5.27 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 10.27 | 105,735 | 1,085,898 | 38,948 | |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 10.27 | 30,317 | 311,356 | 144,683 | |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 42.13 | 22,179 | 934,399 | 2,268,557 | 2.3 M to 2.3 M (-0.97 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 41.46 | 83,556 | 3,463,872 | 2,290,736 | 2.4 M to 2.3 M (-3.52 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 10.27 | 105,735 | 1,085,898 | 2,374,292 | 2.3 M to 2.4 M (+4.66 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 41.01 | 30,317 | 1,243,170 | 2,268,557 | 2.3 M to 2.3 M (-1.32 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 10.27 | 30,317 | 311,356 | 2,298,874 | 2.3 M to 2.3 M (+1.34 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 23,333 | 0 | 46,667 | |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 30,000 | 0 | 30,000 | |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 33,334 | 0 | 0 | |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Payment of Exercise | F | 39.55 | 46,965 | 1,857,466 | 2,268,557 | 2.3 M to 2.3 M (-2.03 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 23,333 | 0 | 2,315,522 | 2.3 M to 2.3 M (+1.02 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 30,000 | 0 | 2,292,189 | 2.3 M to 2.3 M (+1.33 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 33,334 | 0 | 2,262,189 | 2.2 M to 2.3 M (+1.50 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.30 | 279,166 | 1,758,746 | 0 | |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 35.60 | 1,500 | 53,393 | 2,228,855 | 2.2 M to 2.2 M (-0.07 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 34.69 | 54,936 | 1,905,477 | 2,230,355 | 2.3 M to 2.2 M (-2.40 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 33.86 | 29,290 | 991,633 | 2,285,291 | 2.3 M to 2.3 M (-1.27 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 32.65 | 14,969 | 488,726 | 2,314,581 | 2.3 M to 2.3 M (-0.64 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 31.76 | 32,780 | 1,041,076 | 2,329,550 | 2.4 M to 2.3 M (-1.39 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 30.79 | 78,581 | 2,419,116 | 2,362,330 | 2.4 M to 2.4 M (-3.22 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 29.23 | 31,335 | 915,869 | 2,440,911 | 2.5 M to 2.4 M (-1.27 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 28.44 | 14,134 | 401,955 | 2,472,246 | 2.5 M to 2.5 M (-0.57 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 27.30 | 21,641 | 590,866 | 2,486,380 | 2.5 M to 2.5 M (-0.86 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.30 | 279,166 | 1,758,746 | 2,508,021 | 2.2 M to 2.5 M (+12.53 %) |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 74,986 | 449,916 | 0 | |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 79,259 | 475,554 | 74,986 | |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 5,755 | 34,530 | 154,245 | |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.85 | 74,986 | 1,038,909 | 2,228,855 | 2.3 M to 2.2 M (-3.25 %) |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 74,986 | 449,916 | 2,303,841 | 2.2 M to 2.3 M (+3.36 %) |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.58 | 79,259 | 1,076,084 | 2,228,855 | 2.3 M to 2.2 M (-3.43 %) |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 79,259 | 475,554 | 2,308,114 | 2.2 M to 2.3 M (+3.56 %) |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 5,755 | 80,570 | 2,228,855 | 2.2 M to 2.2 M (-0.26 %) |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 5,755 | 34,530 | 2,234,610 | 2.2 M to 2.2 M (+0.26 %) |
Mar 06 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 11.02 | 230,000 | 2,534,600 | 230,000 | |
Mar 06 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 0.00 | 70,000 | 0 | 70,000 | |
Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 36,762 | 220,572 | 160,000 | |
Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.16 | 36,762 | 447,092 | 2,228,855 | 2.3 M to 2.2 M (-1.62 %) |
Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 36,762 | 220,572 | 2,265,617 | 2.2 M to 2.3 M (+1.65 %) |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 12,895 | 77,370 | 196,762 | |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 7,275 | 43,650 | 209,657 | |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.00 | 12,895 | 154,771 | 2,228,855 | 2.2 M to 2.2 M (-0.58 %) |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 12,895 | 77,370 | 2,241,750 | 2.2 M to 2.2 M (+0.58 %) |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.04 | 7,275 | 87,599 | 2,228,855 | 2.2 M to 2.2 M (-0.33 %) |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 7,275 | 43,650 | 2,236,130 | 2.2 M to 2.2 M (+0.33 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 30,000 | 0 | 60,000 | |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 33,333 | 0 | 33,334 | |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 33,334 | 0 | 0 | |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Payment of Exercise | F | 10.91 | 52,806 | 576,113 | 2,228,855 | 2.3 M to 2.2 M (-2.31 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 30,000 | 0 | 2,281,661 | 2.3 M to 2.3 M (+1.33 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 33,333 | 0 | 2,251,661 | 2.2 M to 2.3 M (+1.50 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 33,334 | 0 | 2,218,328 | 2.2 M to 2.2 M (+1.53 %) |
Nov 09 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 7,211 | 43,266 | 216,932 | |
Nov 09 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.00 | 7,211 | 86,554 | 2,184,994 | 2.2 M to 2.2 M (-0.33 %) |
Nov 09 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 7,211 | 43,266 | 2,192,205 | 2.2 M to 2.2 M (+0.33 %) |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 100 | 600 | 224,143 | |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 100 | 600 | 224,143 | |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 10,757 | 64,542 | 224,243 | |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 10,757 | 64,542 | 224,243 | |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.10 | 100 | 1,410 | 2,184,994 | 2.2 M to 2.2 M (0.00 %) |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.10 | 100 | 1,410 | 2,184,994 | 2.2 M to 2.2 M (0.00 %) |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 100 | 600 | 2,185,094 | 2.2 M to 2.2 M (0.00 %) |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 100 | 600 | 2,185,094 | 2.2 M to 2.2 M (0.00 %) |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 10,757 | 150,618 | 2,184,994 | 2.2 M to 2.2 M (-0.49 %) |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 10,757 | 150,618 | 2,184,994 | 2.2 M to 2.2 M (-0.49 %) |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 10,757 | 64,542 | 2,195,751 | 2.2 M to 2.2 M (+0.49 %) |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 10,757 | 64,542 | 2,195,751 | 2.2 M to 2.2 M (+0.49 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 27,928 | 167,568 | 235,000 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 30,932 | 185,592 | 262,928 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 17,798 | 106,788 | 182,202 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 16,140 | 96,840 | 293,860 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.01 | 27,928 | 363,293 | 2,184,994 | 2.2 M to 2.2 M (-1.26 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 27,928 | 167,568 | 2,212,922 | 2.2 M to 2.2 M (+1.28 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.00 | 30,932 | 402,150 | 2,184,994 | 2.2 M to 2.2 M (-1.40 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 30,932 | 185,592 | 2,215,926 | 2.2 M to 2.2 M (+1.42 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.14 | 17,798 | 216,137 | 2,184,994 | 2.2 M to 2.2 M (-0.81 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.00 | 16,140 | 209,885 | 2,202,792 | 2.2 M to 2.2 M (-0.73 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 33,938 | 203,628 | 2,218,932 | 2.2 M to 2.2 M (+1.55 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 27,928 | 167,568 | 235,000 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 30,932 | 185,592 | 262,928 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 17,798 | 106,788 | 182,202 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 16,140 | 96,840 | 293,860 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.01 | 27,928 | 363,293 | 2,184,994 | 2.2 M to 2.2 M (-1.26 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 27,928 | 167,568 | 2,212,922 | 2.2 M to 2.2 M (+1.28 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.00 | 30,932 | 402,150 | 2,184,994 | 2.2 M to 2.2 M (-1.40 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 30,932 | 185,592 | 2,215,926 | 2.2 M to 2.2 M (+1.42 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.14 | 17,798 | 216,137 | 2,184,994 | 2.2 M to 2.2 M (-0.81 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.00 | 16,140 | 209,885 | 2,202,792 | 2.2 M to 2.2 M (-0.73 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 33,938 | 203,628 | 2,218,932 | 2.2 M to 2.2 M (+1.55 %) |
May 17 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 17,798 | 106,788 | 0 | |
May 17 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 82,202 | 493,212 | 17,798 | |
May 17 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 100,000 | 600,000 | 100,000 | |
May 17 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.14 | 17,798 | 216,137 | 2,184,994 | 2.2 M to 2.2 M (-0.81 %) |
May 17 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 17,798 | 106,788 | 2,202,792 | 2.2 M to 2.2 M (+0.81 %) |
May 17 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.26 | 82,202 | 1,007,665 | 2,184,994 | 2.3 M to 2.2 M (-3.63 %) |
May 17 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 82,202 | 493,212 | 2,267,196 | 2.2 M to 2.3 M (+3.76 %) |
May 17 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 11.32 | 100,000 | 1,132,060 | 2,184,994 | 2.3 M to 2.2 M (-4.38 %) |
May 17 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 100,000 | 600,000 | 2,284,994 | 2.2 M to 2.3 M (+4.58 %) |
May 03 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 32,873 | 197,238 | 200,000 | |
May 03 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 17,127 | 102,762 | 232,873 |